New research finds that ivermectin could help control malaria transmission

9 months ago

Malaria remains a significant global health issue with 263 million cases and 597,000 deaths reported in 2023.
Current vector control methods like insecticidal nets and indoor spraying are becoming less effective due to mosquito resistance and behavioral changes.
The BOHEMIA trial demonstrated a 26% reduction in new malaria infections when ivermectin was used alongside bed nets.
Ivermectin, traditionally used for diseases like river blindness, kills mosquitoes feeding on treated individuals, reducing malaria transmission.
Trials in Kenya and Mozambique showed ivermectin's efficacy and safety, with notable reductions in malaria infection rates.
Community engagement and collaboration with health authorities were crucial for the trial's success in Mozambique.
Ivermectin also provided collateral benefits, reducing skin infestations like scabies and head lice.
The WHO has reviewed the findings and recommended further studies, potentially integrating ivermectin into malaria control programs.
Ivermectin could complement existing tools, offering a new approach to malaria prevention in endemic areas.

Hasty Briefsbeta